+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Buprenorphine Patches Market - Global Forecast 2026-2032- Product Image
Buprenorphine Patches Market - Global Forecast 2026-2032- Product Image
Sale

Buprenorphine Patches Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125335
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Buprenorphine Patches Market is projected to reach USD 3.06 Billion in 2026. It is expected to continue growing at a CAGR of 12.53%, reaching USD 6.12 Billion by 2032.

Buprenorphine Patches: Executive Summary and Market Context

Buprenorphine patches are transdermal medicines designed to deliver buprenorphine over an extended period for selected pain-management applications. Their clinical value is associated with continuous dosing, reduced reliance on frequent oral administration, and suitability for some patients who experience difficulty with other dosage forms. Adoption is shaped by prescribing guidance, regulatory status, reimbursement, patient-selection criteria, and the availability of pain-management alternatives.

How Care Pathways Are Reshaping Buprenorphine Patch Use

The landscape is shifting toward more individualized pain care, stronger opioid stewardship, and closer monitoring of treatment effectiveness and safety. Clinicians increasingly weigh non-opioid therapies, multimodal care, functional outcomes, and patient-specific risk factors before selecting an opioid formulation. For patches, practical considerations include adherence, skin tolerance, dose titration, handling instructions, contraindications, and continuity of supply across outpatient and community-care settings.

Artificial Intelligence’s Cumulative Impact on Patch-Based Pain Care

Artificial intelligence can support buprenorphine patch care through clinical-documentation review, identification of medication-safety signals, adherence-risk assessment, and decision support aligned with approved labeling and local guidance. Predictive tools may help prioritize follow-up for patients with inadequate pain control, adverse-effect concerns, or potential misuse risk. However, AI should remain subject to clinician oversight, transparent validation, privacy safeguards, and controls against biased recommendations; it should not replace prescribing judgment or individualized assessment.

Regional Insights Across Six Healthcare Landscapes

North America is characterized by opioid-stewardship initiatives, structured prescribing controls, and varied reimbursement arrangements. Europe places strong emphasis on harmonized medicines regulation alongside national health-technology assessment and prescribing systems. Asia-Pacific combines advanced pharmaceutical markets with rapidly evolving access and pain-care infrastructure. Latin America’s adoption is influenced by regulatory capacity, public-sector procurement, and uneven specialist access. The Middle East is shaped by centralized healthcare systems, controlled-medicine requirements, and expanding specialty services. Africa presents wide variation in analgesic availability, regulatory implementation, and access to trained pain-care professionals; education and reliable distribution remain important priorities.

Group-Level Signals Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets reflect substantial diversity in regulatory maturity, healthcare financing, and access to specialist pain services, making country-specific implementation important. BRICS members face differing balances between domestic production, controlled-medicine regulation, public procurement, and specialist capacity. The European Union benefits from shared regulatory principles while retaining national differences in reimbursement and clinical practice. G7 systems generally have stronger pharmacovigilance, digital-health infrastructure, and opioid-governance frameworks, but access and prescribing patterns still vary. GCC countries commonly combine centralized purchasing and modern hospital systems with stringent controls for controlled medicines. NATO membership spans distinct national health systems, so its relevance is primarily institutional and logistical rather than a unified medicines market.

Country-Level Considerations for Access and Clinical Adoption

Australia, Canada, Japan, South Korea, and the United States have established regulatory and clinical infrastructures but differ in reimbursement, prescribing controls, and pain-service pathways. China and India combine large and diverse healthcare systems with regional variation in specialist access, regulation, and procurement. Brazil, Mexico, and Russia face distinct public-sector, distribution, and regulatory considerations that can influence continuity of treatment. France, Germany, Italy, Spain, and the United Kingdom operate within mature European frameworks, while national formularies, prescribing guidance, reimbursement decisions, and local care pathways shape practical use. Across all listed countries, safe adoption depends on approved indications, clinician education, patient monitoring, and dependable supply.

Practical Priorities for Leaders in Buprenorphine Patch Care

Industry leaders should prioritize evidence aligned with approved uses, transparent safety communication, and education on patient selection, application, storage, disposal, and follow-up. Access strategies should account for national reimbursement rules, controlled-medicine requirements, pharmacy workflows, and rural or underserved populations. Robust pharmacovigilance, supply-chain resilience, and responsible digital tools can strengthen confidence without encouraging inappropriate opioid use. Partnerships with pain specialists, primary-care providers, pharmacists, regulators, and patient organizations can help measure outcomes such as function, adherence, adverse events, and continuity of care.

Research Methodology for a Reliable Executive View

This executive summary uses the supplied market definition-buprenorphine patches-and organizes the assessment across the specified regions, country groups, and countries. The analysis is qualitative and focused on verified, broadly applicable factors: regulatory oversight, prescribing practice, reimbursement, healthcare capacity, opioid stewardship, pharmacovigilance, supply reliability, and responsible use of artificial intelligence. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis. Country and group observations should be validated against current regulatory documents, clinical guidelines, formularies, and public-health data before operational decisions are made.

Conclusion: Safe, Evidence-Based Integration Is the Central Opportunity

Buprenorphine patches occupy a specialized role within multimodal pain management rather than serving as a universal solution. Their future use will depend on disciplined patient selection, responsible opioid governance, clear clinical education, equitable access, and monitoring of real-world outcomes. Regional and national differences make localized implementation essential, while carefully governed AI may improve identification of safety and adherence needs. Leaders that combine clinical evidence, regulatory compliance, supply resilience, and patient-centered care will be best positioned to support appropriate use.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Buprenorphine Patches Market, by Product Type
7.1. Introduction
7.2. Matrix Patch
7.3. Reservoir Patch
8. Buprenorphine Patches Market, by Dosage Strength
8.1. Introduction
8.2. 10 Microgram Per Hour
8.3. 20 Microgram Per Hour
8.4. 40 Microgram Per Hour
9. Buprenorphine Patches Market, by Application
9.1. Introduction
9.2. Chronic Pain Management
9.2.1. Cancer Pain
9.2.2. Neuropathic Pain
9.3. Opioid Use Disorder Treatment
9.3.1. Detoxification Therapy
9.3.2. Maintenance Therapy
10. Buprenorphine Patches Market, by End User
10.1. Introduction
10.2. Ambulatory Care Settings
10.3. Home Healthcare
10.4. Hospitals
11. Buprenorphine Patches Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Buprenorphine Patches Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Buprenorphine Patches Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Buprenorphine Patches Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alvogen, Inc.
16.2. Amneal Pharmaceuticals, Inc.
16.3. Camber Pharmaceuticals, Inc.
16.4. Indivior UK Limited
16.5. Lupin Limited
16.6. Purdue Pharma L.P.
16.7. Sandoz International GmbH
16.8. Sun Pharmaceutical Industries Limited
16.9. Teva Pharmaceutical Industries Limited
16.10. Viatris Inc.
16.11. Zydus Lifesciences Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Buprenorphine Patches Market, Years Considered for the Study
FIGURE 2. Global Buprenorphine Patches Market, Research Design
FIGURE 3. Global Buprenorphine Patches Market, Research Framework
FIGURE 4. Global Buprenorphine Patches Market, Data Triangulation
FIGURE 5. Global Buprenorphine Patches Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Buprenorphine Patches Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Buprenorphine Patches Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Buprenorphine Patches Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 9. Global Buprenorphine Patches Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Buprenorphine Patches Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Buprenorphine Patches Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Buprenorphine Patches Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Buprenorphine Patches Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Buprenorphine Patches Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Buprenorphine Patches Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Buprenorphine Patches Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Buprenorphine Patches Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Buprenorphine Patches Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Buprenorphine Patches Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Buprenorphine Patches Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Buprenorphine Patches Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Buprenorphine Patches Market Segmentation & Coverage
TABLE 2. Global Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 3. Global Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Matrix Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Matrix Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Matrix Patch Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Reservoir Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Reservoir Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Reservoir Patch Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 11. Global 10 Microgram Per Hour Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global 10 Microgram Per Hour Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global 10 Microgram Per Hour Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global 20 Microgram Per Hour Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global 20 Microgram Per Hour Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global 20 Microgram Per Hour Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global 40 Microgram Per Hour Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 40 Microgram Per Hour Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 40 Microgram Per Hour Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 21. Global Chronic Pain Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Chronic Pain Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Chronic Pain Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Cancer Pain Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Cancer Pain Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Cancer Pain Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Neuropathic Pain Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Neuropathic Pain Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Neuropathic Pain Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Opioid Use Disorder Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Opioid Use Disorder Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Opioid Use Disorder Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Detoxification Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Detoxification Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Detoxification Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Maintenance Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Maintenance Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Maintenance Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 40. Global Ambulatory Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ambulatory Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ambulatory Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Home Healthcare Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Home Healthcare Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Home Healthcare Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 50. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Buprenorphine Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Buprenorphine Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. North America Buprenorphine Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. North America Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. North America Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 71. North America Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 72. North America Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 73. North America Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 74. North America Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. North America Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 76. Latin America Buprenorphine Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Latin America Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 78. Latin America Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 79. Latin America Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Latin America Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 81. Latin America Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 82. Latin America Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Latin America Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Europe Buprenorphine Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Europe Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Europe Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 87. Europe Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Europe Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 89. Europe Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 90. Europe Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Europe Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Middle East Buprenorphine Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Middle East Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. Middle East Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 95. Middle East Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Middle East Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 97. Middle East Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 98. Middle East Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Middle East Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Africa Buprenorphine Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Africa Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. Africa Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 103. Africa Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Africa Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 105. Africa Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 106. Africa Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Africa Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Global Buprenorphine Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Buprenorphine Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. ASEAN Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 112. ASEAN Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. ASEAN Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 114. ASEAN Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 115. ASEAN Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. ASEAN Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. GCC Buprenorphine Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. GCC Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. GCC Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 120. GCC Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. GCC Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 122. GCC Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 123. GCC Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. GCC Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. European Union Buprenorphine Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. European Union Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. European Union Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 128. European Union Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. European Union Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 130. European Union Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 131. European Union Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. European Union Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. BRICS Buprenorphine Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. BRICS Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. BRICS Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 136. BRICS Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. BRICS Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 138. BRICS Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 139. BRICS Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. BRICS Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. G7 Buprenorphine Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. G7 Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. G7 Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 144. G7 Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. G7 Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 146. G7 Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 147. G7 Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. G7 Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. NATO Buprenorphine Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. NATO Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. NATO Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 152. NATO Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. NATO Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 154. NATO Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 155. NATO Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. NATO Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. Global Buprenorphine Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. United States Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 159. United States Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. United States Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 161. United States Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. United States Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 163. United States Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 164. United States Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. United States Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. Canada Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 167. Canada Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Canada Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 169. Canada Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Canada Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 171. Canada Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 172. Canada Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Canada Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. Mexico Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 175. Mexico Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Mexico Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 177. Mexico Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Mexico Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 179. Mexico Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 180. Mexico Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Mexico Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Brazil Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 183. Brazil Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Brazil Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 185. Brazil Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Brazil Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 187. Brazil Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 188. Brazil Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Brazil Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. United Kingdom Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 191. United Kingdom Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. United Kingdom Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 193. United Kingdom Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. United Kingdom Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 195. United Kingdom Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 196. United Kingdom Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. United Kingdom Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. Germany Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 199. Germany Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Germany Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 201. Germany Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Germany Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 203. Germany Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 204. Germany Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Germany Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. France Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 207. France Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. France Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 209. France Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. France Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 211. France Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 212. France Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. France Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. Russia Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 215. Russia Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Russia Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 217. Russia Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Russia Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 219. Russia Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 220. Russia Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Russia Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. Italy Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 223. Italy Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. Italy Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 225. Italy Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Italy Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 227. Italy Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 228. Italy Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Italy Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Spain Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 231. Spain Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Spain Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 233. Spain Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Spain Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 235. Spain Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 236. Spain Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Spain Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. China Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 239. China Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. China Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 241. China Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. China Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 243. China Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 244. China Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. China Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. India Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 247. India Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. India Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 249. India Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. India Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 251. India Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 252. India Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. India Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. Japan Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 255. Japan Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. Japan Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 257. Japan Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Japan Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 259. Japan Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 260. Japan Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Japan Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Australia Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 263. Australia Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. Australia Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 265. Australia Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. Australia Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 267. Australia Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 268. Australia Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Australia Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. South Korea Buprenorphine Patches Market Size, 2017-2032 (USD Million)
TABLE 271. South Korea Buprenorphine Patches Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. South Korea Buprenorphine Patches Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 273. South Korea Buprenorphine Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. South Korea Buprenorphine Patches Market Size, by Chronic Pain Management, 2017-2032 (USD Million)
TABLE 275. South Korea Buprenorphine Patches Market Size, by Opioid Use Disorder Treatment, 2017-2032 (USD Million)
TABLE 276. South Korea Buprenorphine Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. South Korea Buprenorphine Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 278. Global Buprenorphine Patches Market Share, by Key Player, 2025
TABLE 279. Global Buprenorphine Patches Market, Key Experts

Companies Mentioned

  • Alvogen, Inc.
  • Amneal Pharmaceuticals, Inc.
  • Camber Pharmaceuticals, Inc.
  • Indivior UK Limited
  • Lupin Limited
  • Purdue Pharma L.P.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Naltrexone and Buprenorphine - Global Strategic Business Report - Product Image

Naltrexone and Buprenorphine - Global Strategic Business Report

  • Report
  • 364 Pages
  • Global
From
Topical Analgesic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Topical Analgesic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Pain Relief Patches Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Pain Relief Patches Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 192 Pages
  • Global
From
Pain Patch Market Report 2026 - Product Image

Pain Patch Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Addictions Therapeutics Market Report 2026 - Product Image

Addictions Therapeutics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.